tirzepatide for menopausal weight gain Menopause, & HRT: The Metabolic “Multiplier" Semaglutide and Menopause: Does It

Tirzepatide represents a dual-action GLP-1 and GIP receptor agonist that requires careful dose escalation to achieve optimal weight loss and metabolic outcomes

doi: 10.3389/fpsyg.2020.530425 23 JensenMDRyanDHApovianCMArdJDComuzzieAGDonatoKAet al

Im 42, female, a mom of four, and was eating well and exercising but the weight kept accumulating as years went on

How Tirzepatide Works Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

PlexusDx precision-wellness approach integrates genetic context and biomarker data to support informed conversations with your healthcare provider about optimal treatment duration for your situation

Most people experience modest appetite suppression at this dose but not the dramatic effect they experienced with therapeutic tirzepatide doses